Use of a Decision Aid to Improve Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial

Dawson-Hughes Penning-van Beest, 2008, Loss of treatment benefit due to low compliance with bisphosphonate therapy, Osteoporos Int, 19, 511, 10.1007/s00198-007-0466-1 Rabenda, 2008, Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women, Osteoporos Int, 19, 811, 10.1007/s00198-007-0506-x Siris, 2006, Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases, Mayo Clin Proc, 81, 1013, 10.4065/81.8.1013 Weycker, 2007, Compliance with osteoporosis drug therapy and risk of fracture, Osteoporos Int, 18, 271, 10.1007/s00198-006-0230-y MacLean, 2008, Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis, Ann Intern Med, 148, 197, 10.7326/0003-4819-148-3-200802050-00198 Cramer, 2007, A systematic review of persistence and compliance with bisphosphonates for osteoporosis, Osteoporos Int, 18, 1023, 10.1007/s00198-006-0322-8 Seeman, 2007, Non-compliance: the Achilles' heel of anti-fracture efficacy, Osteoporos Int, 18, 711, 10.1007/s00198-006-0294-8 Kanis, 2007 Wilson, 2007, Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors, J Gen Intern Med, 22, 6, 10.1007/s11606-006-0093-0 Guyatt, 2004, Patients at the center: in our practice, and in our use of language, ACP J Club, 140, A11, 10.7326/ACPJC-2004-140-1-A11 O'Connor, 2009, Decision aids for people facing health treatment or screening decisions, Cochrane Database Syst Rev, 10.1002/14651858.CD001431.pub2 Cuddihy, 2004, A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture, Osteoporos Int, 15, 695, 10.1007/s00198-004-1597-2 Mauck, 2002, The decision to accept treatment for osteoporosis following hip fracture: exploring the woman's perspective using a stage-of-change model, Osteoporos Int, 13, 560, 10.1007/s001980200073 Tosteson, 2003, Early discontinuation of treatment for osteoporosis, Am J Med, 115, 209, 10.1016/S0002-9343(03)00362-0 Weymiller, 2007, Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial, Arch Intern Med, 167, 1076, 10.1001/archinte.167.10.1076 Breslin, 2008, The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes, Patient Educ Couns, 73, 465, 10.1016/j.pec.2008.07.024 Montori, 2007, Creating a conversation: insights from the development of a decision aid, PLoS Med, 4, e233, 10.1371/journal.pmed.0040233 Pencille, 2009, Protocol for the Osteoporosis Choice trial, Trials, 10, 113, 10.1186/1745-6215-10-113 Wells, 2008, Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women, Cochrane Database Syst Rev O'Connor, 1995, Validation of a decisional conflict scale, Med Decis Making, 15, 25, 10.1177/0272989X9501500105 Elwyn, 2005, The OPTION scale: measuring the extent that clinicians involve patients in decision-making tasks, Health Expect, 8, 34, 10.1111/j.1369-7625.2004.00311.x Thom, 1999, Further validation and reliability testing of the Trust in Physician Scale, Med Care, 37, 510, 10.1097/00005650-199905000-00010 Haynes, 2002, Helping patients follow prescribed treatment: clinical applications, JAMA, 288, 2880, 10.1001/jama.288.22.2880 Stephenson, 1993, The rational clinical examination, JAMA, 269, 2779, 10.1001/jama.1993.03500210079036 Karve, 2008, An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients, Med Care, 46, 1125, 10.1097/MLR.0b013e31817924d2 Hess, 2006, Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures, Ann Pharmacother, 40, 1280, 10.1345/aph.1H018 Montori, 2001, Intention-to-treat principle, CMAJ, 165, 1339